Illumina, Inc. (NASDAQ: ILMN) announced new customer breakthroughs in oncology powered by Illumina's spatial transcriptomics, ...

IRB Barcelona has launched Spain’s first fully integrated spatial omics platform, allowing researchers to capture cells' spatial context.

TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow, and the new AGBT data ...

With an incredibly simple workflow, TruPath Genome eliminates traditional library prep. In just 10-15 minutes of hands-on ...

Citronella is widely valued for its fragrance, medicinal potential, and defensive properties, yet the genetic basis of its characteristic ...

Citronella is widely valued for its fragrance, medicinal potential, and defensive properties, yet the genetic basis of its characteristic citronelloid ...

Published as an arXiv preprint, the paper details how unsupervised and self-supervised AI models are matching or surpassing supervised systems while uncovering biological patterns that traditional ...

Endometrial cancer (EC) incidence is rising globally, yet therapeutic progress has lagged behind other solid tumors, in part due to the complexity and ...

Researchers at UCLA Health and UC San Francisco have identified a specific molecular mechanism that explains why certain ...

The collaborations will provide Illumina's customers with workflows for genomic disease characterization and spatial mapping.

Bruker now extends their complete biology approach to mouse research by announcing development of the CosMx Mouse Whole Transcriptome (WTX) assay. The mouse WTX assay will be available for both FFPE ...

SPOT-Met (Weill Cornell Medicine): SPOT-Met (Spatial Predictors Of Tropism and Metastasis), a 1,000-tumor colorectal cancer program described as the world's largest colorectal cancer multimodal ...